Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study.
Conclusion: Nanosomal docetaxel lipid suspension-based chemotherapy was efficacious and well tolerated in the treatment of sarcoma. Further prospective trials are needed to confirm the data.
PMID: 31827370 [PubMed]
Source: Sarcoma - Category: Cancer & Oncology Tags: Sarcoma Source Type: research
More News: Anemia | Bone Cancers | Cancer & Oncology | Chemotherapy | Chondrosarcoma | Docetaxel | Fibrous Histiocytoma | Hematology | Leiomyosarcoma | Malignant Fibrous Histiocytoma | Nanotechnology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Osteosarcoma | Sarcomas | Soft Tissue Sarcoma | Study | Taxotere | Thrombocytopenia
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024